Skip to main content
Fig. 3 | European Journal of Medical Research

Fig. 3

From: Association between P2Y12 inhibitor reloading and in-hospital outcomes for patients with non-ST-segment elevation acute coronary syndrome already on chronic P2Y12 receptor inhibitors therapy in China: findings from the CCC–ACS (improving care for cardiovascular disease in China-acute coronary syndrome) project

Fig. 3

Cumulative Kaplan–Meier curve estimates of effectiveness outcomes during the 15 days in hospital period. Survival curves of MACE and major bleeding were illustrated using Kaplan–Meier curves and compared employing log-rank tests. A, B Data for the primary effectiveness outcomes of a major adverse cardiovascular event (MACE) and the primary safety outcomes in the NSTEACS patients

Back to article page